mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-05 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-05 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-05 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-05 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.26 |
5e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-05 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
6e-05 |